Disclosed are pharmaceutical compositions, particularly oral dosage forms,which comprise two or more enteric coating materials, either as a coating oras part of a matrix dosage form, and methods of making and using the same. Thecompositions are characterized by having a sustained release profile at lowerpH and an accelerated dissolution profile at higher pH.